↓ Skip to main content

PLOS

Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer

Overview of attention for article published in PLOS ONE, January 2012
Altmetric Badge

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
55 Mendeley
Title
Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
Published in
PLOS ONE, January 2012
DOI 10.1371/journal.pone.0030840
Pubmed ID
Authors

Paul H. van der Horst, Yongyi Wang, Ingrid Vandenput, Liesbeth C. Kühne, Patricia C. Ewing, Wilfred F. J. van IJcken, Marten van der Zee, Frederic Amant, Curt W. Burger, Leen J. Blok

Abstract

Every year approximately 74,000 women die of endometrial cancer, mainly due to recurrent or metastatic disease. The presence of tumor infiltrating lymphocytes (TILs) as well as progesterone receptor (PR) positivity has been correlated with improved prognosis. This study describes two mechanisms by which progesterone inhibits metastatic spread of endometrial cancer: by stimulating T-cell infiltration and by inhibiting epithelial-to-mesenchymal cell transition (EMT).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Hong Kong 1 2%
Unknown 53 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 31%
Student > Master 9 16%
Professor > Associate Professor 7 13%
Student > Doctoral Student 6 11%
Student > Bachelor 6 11%
Other 7 13%
Unknown 3 5%
Readers by discipline Count As %
Medicine and Dentistry 23 42%
Agricultural and Biological Sciences 10 18%
Biochemistry, Genetics and Molecular Biology 6 11%
Engineering 2 4%
Social Sciences 1 2%
Other 3 5%
Unknown 10 18%